Patent Assignment
Reel/Frame 018495/0782
Assignment of Assignor's Interest
Recorded: 2006-11-08
Pages: 5
Assignors
MADERNA, ANDREAS
Executed: 2006-10-19
HONG, ZHI
Executed: 2006-11-03
VERNIER, JEAN-MICHEL
Executed: 2006-10-19
Assignee
VALEANT RESEARCH & DEVELOPMENT
3300 HYLAND AVENUE, COSTA MESA, CALIFORNIA, 92626
Covered Property
(1)
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
Application:
60/833,886 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 23, 2007
From: VALEANT RESEARCH & DEVELOPMENT
To: INTRABIOTICS PHARMACEUTICALS, INC.
Reel/Frame 018925/0677 →
Change of Name
Mar 1, 2007
From: INTRABIOTICS PHARMACEUTICALS, INC.
To: ARDEA BIOSCIENCES, INC.
Reel/Frame 018946/0357 →
Security Agreement
Oct 4, 2010
From: ATON PHARMA, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; VALEANT PHARMACEUTICALS INTERNATIONAL; CORIA LABORATORIES, LTD.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 025084/0169 →
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS NORTH AMERICA; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 025950/0048 →